• World MS Day: Novartis launches 7-Day Challenge to ‘Live Like You’ enabling people with MS to better understand their lives with MS

    • 7-Day Challenge integrates wearable technology and social media to track daily activities of people with MS, allowing valuable personal insights to enable change

    • Novartis is collaborating with Tictrac, a personal analytics company, to empower people with MS via a personal tracking system, to learn more about their lives

    • There is a high interest amongst the MS community to learn about their lifestyles in order to make adjustments that can help to improve their daily lives with MS

    Basel, May 28, 2014 – In support of World MS Day, Novartis announced today the launch of the 7-Day Challenge to Live Like You for people with MS. The 7-Day Challenge to Live Like You, one of the first integrations of emerging technological trends by a pharmaceutical company, is simple: using wearable technology or accessing personal online systems that people use on a daily basis, including calendars, social media channels and fitness trackers, people with MS are invited to track their activities for seven days and gain valuable insights into what works best for their lifestyle. The 7-Day Challenge to Live Like You, which can be accessed via http://7daychallenge.tictrac.com, addresses the growing desire amongst the MS community to gather personalized information that will allow them to make decisions on how they can manage their lives with MS. 

    World MS Day was created by the Multiple Sclerosis International Foundation (MSIF) in 2009 to raise global awareness of MS and its impact on approximately 2.3 million people with MS1 around the world. This year’s World MS Day campaign focuses on ‘access’. Importantly, the topic of access spans beyond access to treatment in MS. Increasingly, there is a need for access to relevant and personalized online information that allows people to utilize available tools in order to make adjustments that can help them to manage their MS in a way that best suits their lifestyle.

    “Novartis is a proud supporter of World MS Day, and we recognize the value of providing access to personalized information for the MS community,” said David Epstein, Division Head, Novartis Pharmaceuticals. “As part of our commitment to providing innovative solutions that go beyond treatments, we are delighted to announce the launch of the 7-Day Challenge to Live Like You,  which will empower the MS community to gain valuable insights about themselves and their MS.”

    The 7-Day Challenge to Live Like You is a collaboration between Novartis and Tictrac, an innovative technology company with expertise in tracking user data and turning the data into unique perceptions (e.g. ‘you're more active after a good night's sleep’) that can help people with MS better understand their lifestyle in order to make small changes based on their new insights. Alongside the 7-Day Challenge to Live Like You, Novartis also recently launched Living Like You (
    www.livinglikeyou.com), an online resource community that features personal content for the MS community.

    For people with MS, personalized information and tracking is essential because it can help with symptom management and take the guesswork out of what is and isn’t working – and allow small changes that could help in achieving meaningful results. The tracking does not need to stop after the seven days are up; the 7-Day Challenge to Live Like You online tracking program will still be available to the MS community, to empower people with MS to continue to gain valuable insights about themselves and how to better manage their life with this debilitating disease.

  • Full Press Release

About Novartis

Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines, over-the-counter and animal health products. Novartis is the only global company with leading positions in these areas. In 2013, the Group achieved net sales of USD 57.9 billion, while R&D throughout the Group amounted to approximately USD 9.9 billion (USD 9.6 billion excluding impairment and amortization charges). Novartis Group companies employ approximately 135,000 full-time-equivalent associates and sell products in more than 150 countries around the world. For more information, please visit http://www.novartis.com.

Media Contacts